Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Capital Reinvestment Ratio
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Capital Reinvestment Ratio of 1.27x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥9.12 Million) in capital expenditures (CN¥11.62 Million). Check Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shenzhen Bioeasy Biotechnology Co. Ltd. Capital Reinvestment Ratio (2016–2025)
This chart tracks Shenzhen Bioeasy Biotechnology Co. Ltd.'s Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see Shenzhen Bioeasy Biotechnology Co. Ltd. cash flow conversion.
Annual Capital Reinvestment Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year Capital Reinvestment Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025. See cash generation quality of Shenzhen Bioeasy Biotechnology Co. Ltd. to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | CN¥66.87 Million | CN¥45.90 Million | ▼ -86.5% |
| 2024 | 5.08x | CN¥34.26 Million | CN¥174.10 Million | ▲ +338.4% |
| 2022 | 1.16x | CN¥152.55 Million | CN¥176.85 Million | ▲ +272.4% |
| 2021 | 0.31x | CN¥255.42 Million | CN¥79.51 Million | ▼ -76.0% |
| 2020 | 1.30x | CN¥63.79 Million | CN¥82.84 Million | ▲ +232.1% |
| 2019 | 0.39x | CN¥67.24 Million | CN¥26.29 Million | ▲ +115.1% |
| 2018 | 0.18x | CN¥57.93 Million | CN¥10.53 Million | ▼ -60.3% |
| 2017 | 0.46x | CN¥23.60 Million | CN¥10.82 Million | ▲ +84.4% |
| 2016 | 0.25x | CN¥36.31 Million | CN¥9.03 Million | — |